An upcoming Vivo tablet has passed China’s 3C certification. This tablet appears to be the Vivo Pad 4 Pro, a flagship ...

The Vivo Pad 4 Pro is the upcoming flagship tablet from the brand, which is expected to go official next month in China ...

Vivo is expected to hold a mega launch event in China to unveil multiple products. These include the Vivo X200 Ultra, X200S, ...

Antimicrobial resistance has recently increased due to emerging carbapenem-resistant Klebsiella pneumoniae and extended-spectrum β-lactamase (ESBL)-producing strains of K. pneumoniae. Osaka ...

Unlike some of the new smartphones in the segment, the iQOO Neo 10R skips a dedicated telephoto camera. It houses a 50MP ...

Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by HC Wainwright from $7.50 to $12.50 in a ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...

Capital Infra Trust, an infrastructure investment trust, has raised Rs 2,363 crore through debt securities to strengthen its ...